AJANTPHARM - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 4.2

💊 Ajanta Pharma shows strong technical momentum, high volume, and solid fundamentals — a favorable candidate for intraday trading with breakout potential.

📈 Positive

• 🔹 MACD at 7.31: Bullish crossover supports upward momentum.
• 🔹 RSI at 69.2: Approaching overbought zone, indicating strong buying interest.
• 🔹 Price Above 50 & 200 DMA: Current price (₹2,596) is above both DMAs (₹2,499 & ₹2,593), confirming trend strength.
• 🔹 Volume Surge: 3.28L vs 1Wk avg of 1.56L — strong intraday participation.
• 🔹 ROCE at 33% & ROE at 25.7%: Excellent capital efficiency and shareholder returns.

⚠️ Limitation

• 🔸 RSI Near Overbought: At 69.2, may trigger short-term profit booking.
• 🔸 FII Outflow: Foreign institutional holdings declined by 0.33%.
• 🔸 PEG Ratio at 4.30: Indicates expensive growth expectations.
• 🔸 Quarterly PAT Dip: Slight decline from ₹255 Cr to ₹250 Cr.

🚫 Company Negative News

• 📉 Export Headwinds: Analysts cite pricing pressure in key overseas markets affecting margins.

✅ Company Positive News

• 💊 New Product Launches: Continued rollout of specialty generics in domestic and US markets.
• 📈 Strong EPS: ₹76.1 reflects robust earnings base.

🏦 Industry

• 🧪 Sector: Pharmaceuticals — Specialty Generics & Branded Formulations.
• 📊 Industry PE: 33.1, nearly aligned with AJANTPHARM’s PE of 34.1, indicating fair valuation.

📌 Conclusion

• 📉 Intraday Setup: Strong technicals and volume favor upside; ideal for breakout trades with RSI caution.
• 💰 Optimal Buy Price: ₹2,585–₹2,590 (on minor dips).
• 📈 Profit Exit Level: ₹2,615–₹2,630 (short-term resistance zone).
• 🛑 Stop Loss: ₹2,570 (below 50 DMA).
• ⏳ If Holding: Exit if RSI crosses 71 or price fails to hold above ₹2,590 intraday.

I can also compare AJANTPHARM’s intraday setup with other pharma stocks showing similar momentum today.